| Literature DB >> 27247918 |
Farzaneh Shakeri1, Zahra Gholamnezhad1, Bruno Mégarbane2, Ramin Rezaee3, Mohammad Hosein Boskabady1.
Abstract
Gastrointestinal (GI) diseases affect a large number of people all over the world. Uncontrolled acid secretion and occurrence of gastric ulcers are common disorders of GI tract which pose serious problems to human health. Many synthetic drugs have been used to treat GI disorders but a definite cure has not been discovered so far and the available medications cause several side effects. Nigella sativa (N. sativa) (Ranunculacea) has several therapeutic effects which are attributed to its constituents like nigellicine, nigellidine, thymoquinone, dithymoquinone, thymol and carvacrol. Several beneficial pharmacological properties of this plant such as anti-oxidant, anti-bacterial, anti-histaminic, anti-hypertensive, hypoglycemic, anti-fungal, anti-inflammatory, anti-cancer and immunomodulatory effects were reported and different therapeutic properties such as reliving bronchial asthma, jaundice, hydrophobia, paralysis, conjunctivitis, piles, skin diseases, anorexia, headache, dysentery, infections, obesity, back pain, hypertension and gastrointestinal problems, have been described for the seeds of N. sativa and its oil. The present review provides a detailed summery of scientific researches regarding gastrointestinal effect of N. sativa and its main constituent, thymoquinone.Entities:
Keywords: Gastrointestinal disease; Nigella sativa; Thymoquinone
Year: 2016 PMID: 27247918 PMCID: PMC4884214
Source DB: PubMed Journal: Avicenna J Phytomed ISSN: 2228-7930
Anti cancer effect of N. sativa and thymoquinone in GI tract
|
|
|
|
| |
|---|---|---|---|---|
|
| Colon cancer aberrant crypt foci were induced using1,2-dimethylhydrazine | Reduced total number of aberrant crypt foci | (Salim and Fukushima, 2003) | |
|
| HCT-116 human colorectal cancer cells | Triggered apoptosis via a p53-dependent mechanism | (Gali-Muhtasib et al., 2004) | |
|
| Pancreatic cancer cells | Cytotoxicity of pancreatic cancer cell line FG/COLO357M | (Torres et al., 2010) | |
|
| Pancreatic cancer cells | Reduced growth of cancer cells | (Banerjee et al., 2009) | |
|
| Diethylnitrosamine induced hepatic carcinogenesis | Reduced oxidative stress | (Sayed-Ahmed et al., 2010) | |
Hepatoprotective effect of N. sativa and thymoquinone
|
|
|
|
|
|---|---|---|---|
|
| Hepatic ischemia–reperfusion injury | Reduced levels of liver enzymes | (Yildiz et al., 2008) |
|
| Cholestatic liver injury | Reduced neutrophil infiltration | (Coban et al., 2010) |
|
| Lead acetate induced liver toxicity | Increased AST | (Farrag et al., 2007) |
|
| Trinitrobenzenesulphonic acid (TNBS)-induced colitis | Increased CAT activity | (Emekli-Alturfan et al., 2011) |
|
| Carbon tetrachloride (CCl4) induced liver toxicity | Reduced lipid peroxidation and liver enzymes, | (Kanter et al., 2005a) |
|
| Hepatitis C virus (HCV) infection | Decreased viral load | (Adel et al., 2013) |
|
| Tert-butyl hydroperoxide (TBHP) induced liver toxicity | Reduced leakage of cytosolic enzymes, ALT and AST | (Daba and Abdel-Rahman, 1998) |
|
| Carbon tetrachloride (CCl4) induced liver toxicity | Antioxidant properties | (Nagi et al., 1999) |
|
| Aflatoxin B1 (AFB1) induced liver toxicity | Reduced AST, ALT, ALP and MDA levels | (Nili-Ahmadabadi et al., 2011) |
|
| Sodium fluoride-induced hepatotoxicity | Antagonize the increased LPO | (Abdel-Wahab, 2013) |
|
| Tamoxifen induced liver toxicity | Inhibited glutathione depletion | (Suddek, 2014) |
|
| Hepatorenal dysfunction induced by renal ischaemia-reperfusion | Reduced damage via an antioxidant mechanism | (Awad et al., 2011) |
|
| Acetaminophen induced hepatotoxicity | Reduced in ALT activity | (Nagi et al., 2010) |
Anti-bacterial and anti-schistosomiasis effect of N. sativa and thymoquinone in GI tract
|
|
|
|
|
|---|---|---|---|
|
| Intestinal escherichia coli colonization | Reduced numeration of ileal E. coli | (Boka et al., 2014) |
|
| Schistosomamansoni infection | Biocidal effect in all stages of the parasite Inhibitory effect on egg-laying of adult female worms | (Mohamed et al., 2005) |
|
| Patients with H. pylori | Potential effect on H. pylori activity | (Salem et al., 2010) |
|
| Schistosomamansoni infection | Reduced the number of S. mansoni worms in the liver | (Mahmoud et al., 2002) |
|
| Schistosomamansoni infection | Inhibited most of the hematological and biochemical changes | (Shenawy et al., 2008) |
|
| Bacterial translocation induced by mechanical intestinal obstruction | Reduced inflammatory cytokines, oxidative damage, bacterial translocation | (Kapan et al., 2012) |
Anti-inflammatory and antioxidant effect of N. sativa and thymoquinone in GI tract
|
|
|
|
|
|---|---|---|---|
|
| Ethanol induced gastric mucosal damage | Reduced the number of MC , the area of gastric erosions, histamine levels and myeloperoxidase activity | (Kanter et al., 2006) |
|
| Gastric lesions induced by indomethacin | Reduced the gastric lesions | (Rifat-uz-Zaman and Khan, 2004) |
|
| Gastric lesions induced by indomethacin | Reduced gastric acid-output | (Rifat-uz-Zaman and Khan, 2004) |
|
| Gastric lesions induced by indomethacin | Reduced gastric secretion volume, pH, acid-output and ulcer index. | (Rifat-uz-Zaman and Khan, 2004) |
|
| Gastric lesions induced by indomethacin | Potential effect on pepsin activity, ulcer index and gastric secretion | (Rifat-uz-Zaman and Khan, 2004) |
|
| Gastric mucosal injury induced by ischaemia reperfusion | Reduced LDH, LPX | (El-Abhar et al., 2003) |
|
| Alcohol-induced gastric mucosal injury | Reduced in the ulcer index, MDA | (Kanter et al., 2005b) |
|
| Piroxicam induced gastric mucosal injury | Improved the structure of the mucosa Increased in mucus secretion | (Mohammed et al., 2010) |
|
| Stress gastriculcer in hypothyroidal rats | Reduced in thyroid hormone level increased stress gastritis, and this effect can be inhibited by treatment with | (Abdel Sater, 2009) |
|
| Trinitrobenzene sulfonic acid (TNBS)induced experimental colitis | Reduced the proinflammatory cytokines, lactate dehydrogenase, myeloperoxidase, triglyceride, cholesterol and increasd superoxide dismutase activity. | (Isik et al., 2011) |
|
| Ethanol induced gastric lesions | Increased glutathione and antioxidant enzymes | (El-Masry et al., 2010) |
|
| Ethanol induced ulcer | Increased the gastric mucin, free acidity and glutathione level | (El-Dakhakhny et al., 2000) |
|
| Acetic acid-induced colitis | Antioxidant activity | (Mahgoub, 2003) |
|
| Gastric mucosal ischemia/reperfusion (I/R) injury | Inhibited proton pump, acid secretion and neutrophil infiltration | (Magdy et al., 2012) |
|
| Chronic pancretitis induced by high fat diet and ethanol | Reduced the secretion of amylase and lipase from pancreas, inflammatory cytokine and lipid peroxidation | (Suguna et al., 2013) |